Cargando…
Upregulation of Nogo‐B by hypoxia inducible factor‐1 and activator protein‐1 in hepatocellular carcinoma
Nogo‐B is an important regulator of tumor angiogenesis. Expression of Nogo‐B is remarkably upregulated in multiple tumor types, especially hepatocellular carcinoma (HCC). Here, we show the transcriptional regulation mechanisms of Nogo‐B in liver cancer. In response to hypoxia, expression of Nogo‐B s...
Autores principales: | Han, Dingding, Yang, Penggao, Qin, Bo, Ji, Guoqing, Wu, Yanhua, Yu, Long, Zhang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253276/ https://www.ncbi.nlm.nih.gov/pubmed/33963651 http://dx.doi.org/10.1111/cas.14941 |
Ejemplares similares
-
Nogo‐B promotes tumor angiogenesis and provides a potential therapeutic target in hepatocellular carcinoma
por: Cai, Hao, et al.
Publicado: (2018) -
Knockout of the Nogo-B Gene Attenuates Tumor Growth and Metastasis in Hepatocellular Carcinoma()
por: Zhu, Bo, et al.
Publicado: (2017) -
Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein
por: Dong, Chengyong, et al.
Publicado: (2016) -
Upregulating KTN1 promotes Hepatocellular Carcinoma progression
por: Pan, Jian, et al.
Publicado: (2021) -
Nogo-B promotes angiogenesis and improves cardiac repair after myocardial infarction via activating Notch1 signaling
por: Zheng, Yanjun, et al.
Publicado: (2022)